secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001493152-26-004055
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences raises ~$1.5M in registered direct offering with warrants
-----------------------------------------------------------------------------

- Sold 328,802 shares at $4.41 per share in a registered direct offering, gross proceeds ~$1.5M.
- Concurrent private placement: Series G and H warrants to buy up to 328,802 shares each at $4.16.
- Series G warrants expire 5 years after resale registration effective date; Series H expire 18 months after.
- Net proceeds ~$1.25M for product development, working capital, general corporate purposes.
- H.C. Wainwright acted as placement agent; fees include 7% cash and placement agent warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315226004055/0001493152-26-004055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315226004055/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer